Sargent Investment Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237K Sell
3,329
-232
-7% -$18.3K 0.03% 230
2025
Q4
$292K Buy
+3,561
New +$277K 0.04% 210
2025
Q3
Sell
-3,972
Closed -$278K 165
2025
Q2
$278K Buy
3,972
+50
+1% +$3.48K 0.04% 201
2025
Q1
$317K Buy
3,922
+8
+0.2% +$688 0.05% 182
2024
Q4
$334K Buy
3,914
+215
+6% +$18.3K 0.05% 175
2024
Q3
$347K Sell
3,699
-562
-13% -$47.2K 0.06% 152
2024
Q2
$332K Sell
4,261
-587
-12% -$47.9K 0.07% 150
2024
Q1
$441K Sell
4,848
-1,308
-21% -$109K 0.1% 124
2023
Q4
$476K Sell
6,156
-507
-8% -$35.5K 0.1% 126
2023
Q3
$453K Buy
6,663
+313
+5% +$22.8K 0.11% 126
2023
Q2
$516K Sell
6,350
-238
-4% -$19K 0.13% 115
2023
Q1
$539K Buy
+6,588
New +$470K 0.14% 111

Other funds holding GEHC

Sargent Investment Group's GEHC Position: Q1 2026 in Review

Sargent Investment Group reduced its GE HealthCare (GEHC) stake by 6.5% in Q1 2026, selling an estimated $18.3K and leaving 3,329 shares worth $237K. The position accounts for 0.03% of the portfolio, ranked #230.

Sargent Investment Group first reported a position in GEHC in Q1 2023 and has held it in 12 quarters since. The position peaked at $539K in Q1 2023. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Sargent Investment Group held 3,329 shares of GE HealthCare worth $237K as of Q1 2026.
  • Sargent Investment Group sold 232 GE HealthCare shares in Q1 2026, an estimated $18.3K.
  • GE HealthCare made up 0.03% of Sargent Investment Group's portfolio in Q1 2026, its #230 holding.
  • Sargent Investment Group first reported a position in GE HealthCare in Q1 2023 and has held it in 12 quarters since.
  • Sargent Investment Group's GE HealthCare position peaked at $539K in Q1 2023.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.